Significant alterations in insulin sensitivity and blood lipid levels are linked to RA, particularly when the illness progresses, and metabolic abnormalities such as higher TC, LDL, and TG concentrations are present even in preclinical RA. The gene discussed is INS; the disease is rheumatoid arthritis.